Egan Gail M, Siskin Gary P, Weinmann Robert, Galloway Margy M
Community Care Physicians, Latham, New York, USA.
J Infus Nurs. 2013 May-Jun;36(3):181-8. doi: 10.1097/NAN.0b013e3182893690.
An initial postmarket study of the SecurAcath used with 5 Fr peripherally inserted central catheters (PICCs) was conducted with 68 adult patients at 3 different institutions in the United States. PICCs were placed in both outpatients and inpatients, with patients in critical care and medical/surgical units, home care, and extended care facilities. Sixty-two (91.2%) of the patients completed therapy without a securement-related device malfunction or device-related adverse event associated with the securement system. The device was readily accepted by both patients and nursing staff. The SecurAcath represents a novel, safe, and effective method for catheter securement.
一项针对与5F外周置入中心静脉导管（PICC）一起使用的SecurAcath的上市后初步研究，在美国3家不同机构的68名成年患者中进行。PICC被放置在门诊患者和住院患者中，包括重症监护、内科/外科病房、家庭护理和长期护理机构的患者。62名（91.2%）患者在没有与固定装置相关的故障或与固定系统相关的器械相关不良事件的情况下完成了治疗。该装置很容易被患者和护理人员接受。SecurAcath代表了一种用于导管固定的新颖、安全且有效的方法。
